81
24
Growth Score 81 in past quarter
-6 pts
Heat Score 24 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
494058
Neuritek Therapeutics develops innovative treatments for PTSD and other mental health disorders.
- William Hapworth: Founder
About the Company
Neuritek Therapeutics is a biopharmaceutical company focused on developing innovative treatments for mental health disorders, particularly post-traumatic stress disorder (PTSD). The company aims to revolutionize mental health treatment by addressing the root causes of psychiatric conditions. Neuritek is committed to creating therapies that have the
potential to transform the lives of patients and families affected by these disorders. Their research and development efforts are centered on next-generation therapies that could significantly impact the field of mental health care.